Carolina Equine Clinic, Southern Pines, NC

   
Melanomas In Grey Horses May Hold The Clue For Survival In Other Species
 
It is interesting that Tesio in his book, "Breeding The Race Horse", described the inheritance of the grey coat color similar to the inheritance of a disease or defect. On the other hand, the grey horse can survive melanoma tumors better than any other species that develops them. While horse owners worry about their grey horse’s tumors, scientists recognize that the horse must harbor the secret to surviving melanoma.

In the 1970’s I experimented on some otherwise healthy, melanoma-bearing , retired grey horses by administering autogenous tumor vaccines made by Dr Vincent Saurino in Boca Raton FL. In one individual horse after receiving a series of vaccinations made from his own tumor, some areas of skin including the tumors on his tail lost its black pigment. This is a process called vitiligo. More recent research shows that it may hold the key to the cure for melanoma.


Pre-op Melanoma
I recently met a researcher, Dr John Powderly, whose expertise on melanoma in several species, including man, has led him to do more work on immunotherapy and the possible triggering of vitiligo. In mice, man, horse and a special breed of swine called Sinclair swine, vitiligo has been associated with melanoma regression.

Sinclair swine are the most dramatic example of the power of vitiligo in the cure of melanoma. 84% of these miniature, black swine are born with cutaneous nevi which develop into melanomas within the first six weeks of life. Greater than 50% of the tumors spread to internal organs. Some of these die by the age of 6 weeks. Many survive their malignancy as vitiligo begins around 6 months of age. The tumors then undergo regression. The black pigs turn totally white as their tumors shrink. Experiments in these swine have shown that the vitiligo process, though not well understood, is enhanced by hormones and immune competance.


Post-op
I have seen unusually developing white skin in horses in response to hormones, inflammatory insults from infestations to trauma and even post surgical procedures.

Melanoma-associated-vitiligo and immune mechanisms against pigment cell antigens occur in the Sinclair swine and the grey horse. If the vitiligo is a manifestation of the immune system’s breaking of self-tolerance, then the white patterns indicate that antigens on melanocytes can be distinguished as targets. In studies in mice and man, the development of non-pigmented skin occurs in body stripes which corresponds to a dermatome, or body segment. The striped patterns of vitiligo suggest unique dermatome-specific antigens. Since melanocytes originate embryologically at the site of the central nervous system (neural crest), it makes sense to derive a vaccine from nervous (dendritic) tissue. Dr Powderly is working on development of a dendritic melanoma vaccine. This is an effort to immunologically turn on the vitiligo process and achieve regression of the melanoma.


5 Weeks Post-op
There have been four documented cases in man of melanoma regression associated with vitiligo. In all cases vitiligo had crept over the dermatome where the primary melanoma was situated, and the tumor regressed. These are rare cases in man, but it is the pattern of regression seen in Sinclair swine where the vitiligo is generalized.

Vitiligo in the horse is sometimes bilaterally symmetrical and segmental when it appears to be immune and/or homonally regulated. In my experience it is not as common in other coat colors as it is in grey horses, where the pattern is often random. Although I have not seen spontaneous total regression of melanomas in the horse as occurs in Sinclair swine, I have seen and had reports of retarded growth and even partial regression of melanomas in horses that have had some form of immunotherapy. I have not been aware of the role that vitiligo may play in the process; however, when I have debulked a rapidly growing melanoma from the perineum or tail and left it to heal as an open wound, the remaining black tumor tissue is replaced by healthy pink granulation tissue. Skin then heals over the pink tissue. I’ve always believed that granulation tissue in the secondary healing process has an increased immune capability, and it would appear to be true when granulation tissue replaces melanoma in the grey horse.
As we anticipate some breakthrough in development of an immune stimulant in the fight against melanoma in man, we continue to look to animal models for some clues on the direction the research should take. Veterinarians will continue to use their tools of immunotherapy and surgery to enhance the grey horses’ ablity to coexist with his melanoma. The grey horse perhaps holds the secret to survival from melanoma for us, his caretakers.